Chlorambucil (CBL) is an alkylating agent, which widely use in the treatment of various types of tumors. The main purpose of this study is to evaluate the in-vivo biodistribution of CBL conjugated to the anionic dendrimer, which has a great ability to labeled with Tc through binding to carboxylate terminate groups. Whole body scans were used to analyze the percentage of the injected dose in different times. Radiochemical purity (RCP) and in-vivo biodistribution were also calculated with the SPECT/CT instrument. Our study proposes a new method for RCP determination and shows that this carrier is a promising agent to complex with the Tc and biological assessment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-0042-118448 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!